CRISPR-based genome editing of clinically important Escherichia coli SE15 isolated from indwelling urinary catheters of patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Sangrim | - |
dc.contributor.author | Kim, Jinsoo | - |
dc.contributor.author | Hur, Junho K. | - |
dc.contributor.author | Lee, Sang-Seob | - |
dc.date.accessioned | 2022-07-14T20:05:47Z | - |
dc.date.available | 2022-07-14T20:05:47Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 0022-2615 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153026 | - |
dc.description.abstract | Urinary tract infections (UTIs) are clinically important problems that lead to serious morbidity and mortality, and indwelling urinary catheters are a major factor of UTIs. In this study, we applied clustered regularly interspaced short palindromic repeats (CRISPR) genome editing to generate ΔluxS mutant strains from clinical isolates of Escherichia coli SE15, which is one of major pathogens and can cause colonization and biofilm formation in the catheter. A major regulatory pathway of such biofilm formation on medical devices is the quorum sensing mechanism via small molecule autoinducer-2 synthesized by LuxS enzyme. Here, we used the CRISPR-Cas9 system for precise deletion of luxS gene in clinical isolate E. coli SE15. To this end, we constructed a donor DNA for homologous recombination to delete 93 bases in the chromosomal target (luxS) and observed the success rate of luxS deletion to be 22.7%. We conducted biofilm assay to observe decreased biofilm formation in the E. coil SE15 ΔluxS mutants compared to wild-type E. coil SE15. Quantitative real-time PCR analysis of E. coil SE15 ΔluxS mutants showed that the expression of luxS was below detection level. We also observed that the relative mRNA levels of biofilm-formation-related genes, such as mqsR, pgaBC and csgEF, were significantly decreased in E. coil SE15 ΔluxS mutants compared to wild-type. We conclude that genome editing by CRISPR-Cas9 system is an effective tool to dissect the molecular mechanism of biofilm formation in medically important strains, and the study may serve as a basis for developing novel medical intervention against UTIs caused by biofilm. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MICROBIOLOGY SOC | - |
dc.title | CRISPR-based genome editing of clinically important Escherichia coli SE15 isolated from indwelling urinary catheters of patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hur, Junho K. | - |
dc.identifier.doi | 10.1099/jmm.0.000406 | - |
dc.identifier.scopusid | 2-s2.0-85014333524 | - |
dc.identifier.wosid | 000396117600004 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICAL MICROBIOLOGY, v.66, no.1, pp.18 - 25 | - |
dc.relation.isPartOf | JOURNAL OF MEDICAL MICROBIOLOGY | - |
dc.citation.title | JOURNAL OF MEDICAL MICROBIOLOGY | - |
dc.citation.volume | 66 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 18 | - |
dc.citation.endPage | 25 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.subject.keywordAuthor | Biofilm | - |
dc.subject.keywordAuthor | CRISPR-Cas9 system | - |
dc.subject.keywordAuthor | E. coli SE15 | - |
dc.subject.keywordAuthor | LuxS gene | - |
dc.subject.keywordAuthor | UTIs | - |
dc.identifier.url | https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.000406 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.